Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125063693 | 12506369 | 3 | F | 20160205 | 20160902 | 20160628 | 20160906 | EXP | RO-ABBVIE-16P-135-1555854-00 | ABBVIE | 60.79 | YR | M | Y | 0.00000 | 20160906 | MD | COUNTRY NOT SPECIFIED | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125063693 | 12506369 | 1 | PS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 2 TABL/DAY IN THE MORNING | 506408D | 206619 | |||||||||
| 125063693 | 12506369 | 2 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 506408D | 206619 | |||||||||||
| 125063693 | 12506369 | 3 | SS | EXVIERA | DASABUVIR | 1 | Oral | 2*1 TABL/DAY | 506828D | 206619 | |||||||||
| 125063693 | 12506369 | 4 | SS | EXVIERA | DASABUVIR | 1 | 506828D | 206619 | |||||||||||
| 125063693 | 12506369 | 5 | SS | REBETOL | RIBAVIRIN | 1 | Oral | Y | 0 | ||||||||||
| 125063693 | 12506369 | 6 | SS | REBETOL | RIBAVIRIN | 1 | Oral | Y | 0 | ||||||||||
| 125063693 | 12506369 | 7 | C | BETALOK ZOK | 2 | Oral | 0 | ||||||||||||
| 125063693 | 12506369 | 8 | C | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 0 | |||||||||||
| 125063693 | 12506369 | 9 | C | NOVORAPID INSULIN | 2 | Subcutaneous | 10 IU AT 13.00, NOON | 0 | |||||||||||
| 125063693 | 12506369 | 10 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 10 IU AT 18.30, EVENING | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125063693 | 12506369 | 1 | Hepatitis C |
| 125063693 | 12506369 | 2 | Hepatic cirrhosis |
| 125063693 | 12506369 | 3 | Hepatic cirrhosis |
| 125063693 | 12506369 | 4 | Hepatitis C |
| 125063693 | 12506369 | 5 | Hepatitis C |
| 125063693 | 12506369 | 6 | Hepatic cirrhosis |
| 125063693 | 12506369 | 7 | Hypertension |
| 125063693 | 12506369 | 8 | Hypertension |
| 125063693 | 12506369 | 9 | Type 2 diabetes mellitus |
| 125063693 | 12506369 | 10 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125063693 | 12506369 | HO |
| 125063693 | 12506369 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125063693 | 12506369 | Anaemia | |
| 125063693 | 12506369 | Cardio-respiratory arrest | |
| 125063693 | 12506369 | Haemorrhagic stroke | |
| 125063693 | 12506369 | Hepatic failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125063693 | 12506369 | 1 | 20160111 | 20160403 | 0 | |
| 125063693 | 12506369 | 3 | 20160111 | 20160403 | 0 | |
| 125063693 | 12506369 | 5 | 20160111 | 0 | ||
| 125063693 | 12506369 | 6 | 20160403 | 0 | ||
| 125063693 | 12506369 | 7 | 2010 | 0 | ||
| 125063693 | 12506369 | 8 | 2015 | 0 | ||
| 125063693 | 12506369 | 9 | 201501 | 0 | ||
| 125063693 | 12506369 | 10 | 201501 | 0 |